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Edited by Laszlo NagyAbstract Macrophage ionotropic P2X7 receptors regulate cell-
death through ill-deﬁned signaling pathways. Here, we investi-
gated the role of ceramide, an apoptogenic sphingolipid and
showed that ATP stimulated ceramide accumulation in macro-
phages. Benzoylbenzoyl-ATP, a potent P2X7 agonist, was able
to mimic the eﬀects of ATP on ceramide accumulation while oxi-
dized ATP had the opposite eﬀect. Ceramide accumulation was
blocked by de novo ceramide biosynthesis inhibitors. Interest-
ingly, ATP-induced caspase-3/7 activation was dependent on cer-
amide generation. Finally, we showed that de novo ceramide
biosynthesis is involved in ATP-induced macrophage death in a
caspase-dependent manner. Our results indicate a novel role of
ceramide in P2X7-regulated cell-death.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
Keywords: Purinergic P2X7 receptor; Caspase; Ceramide;
Cell-death; Macrophage1. Introduction
The P2X7 receptor (P2X7) subclass belongs to the P2X fam-
ily of ATP-gated ion channels [1,2]. It contains two putative
membrane-spanning domains and a large extracellular loop,
structural features that are characteristic of members of the
P2X family. Unlike other P2X receptors, P2X7 has a longer
C-terminal region that is thought to be functionally important
for its function [1,2]. It has been shown that activation of P2X7
by ATP mediates fast permeability changes to cations [1,2].
Upon prolonged activation, P2X7 induces the formation of
non-selective membrane pores permeable to molecules up to
900 Da [2]. At present, the mechanisms controlling the opening
of the cation channel as well as its transition or coupling to a
pore remain unknown. However, some evidence suggest that
the cytoplasmic C-terminal part of P2X7 is involved [3–5].Abbreviations: P2X7, purinergic P2X7 receptors; BzATP, 2 0,3 0-O-
(benzoyl-4-benzoyl)-ATP; oATP, oxidized ATP; LDH, lactate
dehydrogenase; PDMP, d-threo-1-phenyl-2-decanoylamino-3-mor-
pholino-1-propanol; CS, cycloserine; bChlor, b-chloroalanine; ISP-1,
myriocin
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doi:10.1016/j.febslet.2005.11.066Depending on the cell type, activation of P2X7 is known to
mediate biological processes such as the release of cytokines
and the killing of pathogenic bacteria [2,6]. A role for P2X7
has also been proposed in ATP-triggered cell-death by necrosis
and/or apoptosis of several cell types, including myeloid cells
[6], dendritic cells [7], thymocytes [9,10] and macrophages
[11,12]. Stimulation of P2X7 by ATP triggers several intracel-
lular signaling events, among which are activation of stress-
activated protein kinase [11], extracellular-regulated kinase
1/2 [13], caspases [14] and phospholipase D [10,15]. However,
the signaling pathways leading to ATP-induced cell-death are
not yet fully understood.
The sphingolipid metabolite, ceramide, has recently emerged
as an important second messenger that may mediate a number
of biological processes, including induction of cell-death
[16,17]. Ceramide is produced in vivo by de novo biosynthesis
and by turnover of complex sphingolipids [18,19]. In the latter
pathway, ceramide is produced by activation of sphingomy-
elinases in response to a variety of apoptotic agonists including
the tumor necrosis factor-a (TNFa). De novo synthesis of cer-
amide occurs at the cytosolic face of the endoplasmic reticulum
and is initiated by the condensation of serine and palmitoyl-
CoA catalyzed by serine palmitoyltransferase. Various antitu-
mor agents induce apoptosis through de novo biosynthesis of
ceramide. In order to mediate its cellular eﬀects, ceramide
has been shown to activate a number of enzymes involved in
stress signaling cascades [16,18,20] including protein kinases,
protein phosphatases and caspases as well as mitochondrial
alterations.
In the present study, we investigated the role of ceramide in
response to ATP-induced macrophage death. We found that
ATP induces ceramide accumulation through the speciﬁc acti-
vation of P2X7. This ceramide production is totally dependent
on the de novo biosynthesis pathway. Using inhibitors of de
novo ceramide synthesis, it was found that ceramide accumu-
lation is involved in the propagation of caspase-dependent
macrophage death induced by P2X7 stimulation.2. Materials and methods
2.1. Reagents and cell culture
Tissue culture medium was from Gibco, Life Technologies.
[c-32P]ATP was purchased from Perkin Elmer Life Sciences. ATP,
UTP, 2 0,3 0-O-(benzoyl-4-benzoyl)-ATP (BzATP), oxidized ATP
(oATP), b-chloroalanine (bChlor), L-cycloserine (CS), and lactate
dehydrogenase (LDH) detection kit were from Sigma Chemicals Co.
N-Benzoyloxycarbonyl-Val-Ala-Asp-ﬂuoromethylketone (ZVAD),
Myriocin (ISP-1) and d-threo-1-phenyl-2-decanoylamino-3-morpho-
lino-1-propanol (PDMP) were from Biomol. Diacylglycerol (DAG) ki-
nase was from Calbiochem. All solvents were from Merck Eurolab.blished by Elsevier B.V. All rights reserved.
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virus transformed macrophages [21]. These cells were grown in RPMI
1640 medium buﬀered with HEPES, containing 10% fetal bovine ser-
um and 100 U/ml penicillin, 100 lg/ml streptomycin.
2.2. Measurement of lactate dehydrogenase release
RAW 264.7 macrophages were incubated at 37 C with ATP with or
without drugs, in RPMI supplemented with 1 mg/ml lipid-free bovine
serum abumin (BSA) and 0.5 mM CaCl2. At the end of the incubation
period, LDH release in culture medium was measured as previously de-
scribed [10]. Results are expressed as a percentage of LDH released.
Each measurement was done in duplicate.
2.3. Measurement of ceramide levels
RAW 264.7 macrophages were incubated at 37 C with ATP with or
without drugs, in RPMI supplemented with 1 mg/ml lipid-free BSA
and 0.5 mM CaCl2. Ceramide and total phospholipid levels in cellular
lipid extracts were measured from cellular lipid extracts as previously
described [22]. Results are expressed as pmol of ceramide/nmol of
phospholipids.
2.4. Measurement of caspase-3/7 activity
Caspase-3/7 activity was measured by the Apo-ONE homogeneous
caspase-3/7 assay (Promega). RAW 264.7 macrophages were incubated
at 37 C with ATP with or without drugs, in RPMI supplemented with
1 mg/ml lipid-free BSA and 0.5 mM CaCl2. Caspase activity was mea-
sured according to the manufacturers instructions using a Wallac 1420
Perkin Elmer plate reader thermostated at 37 C (reading every 6 min
within a 3-h period). Each measurement was done in triplicate. Results
represent the initial rate of caspase activity expressed as arbitrary units.
2.5. Statistical analysis
Data are expressed as means ± S.E.M. Signiﬁcance was assessed by
the Students t test for paired samples. P values less than 0.05 were con-
sidered as signiﬁcant.Fig. 1. ATP induces ceramide accumulation in RAW 264.7 macro-
phages. Cells were incubated with 3 mM ATP for the indicated times
(A) or various concentrations of ATP for 2 h (B). Ceramide levels were
then determined as described in Section 2. Data are means ± S.E.M of
three independent experiments.3. Results and discussion
3.1. ATP induces ceramide accumulation in RAW 264.7
macrophages
In order to determine if ATP modulates ceramide levels in
RAW 264.7 macrophages, we measured the ceramide mass
after derivatization into ceramide-1-phosphate by the Esche-
richia coli DAG kinase [22]. We found that treatment of mac-
rophages with 3 mM ATP resulted in an increase (2.5-fold) in
ceramide levels that started 15–30 min following treatment and
plateaued after 1–2 h (Fig. 1A). In contrast, ATP pulse (30 min
stimulation with ATP followed by 1.5 h without ATP) did not
raise ceramide levels in macrophages (data not shown), indi-
cating that prolonged purinergic stimulation is required. In
addition, we showed that ATP stimulated ceramide production
in a dose-dependent manner (Fig. 1B). Increasing the ATP
concentration up to 5 mM enhanced ceramide levels by about
2-fold with a maximal eﬀect at a concentration of 2 mM.
3.2. ATP induces ceramide accumulation through P2X7
activation
RAW 264.7 macrophages express not only P2X7 receptors
but also G protein-coupled P2Y receptors [23,24]. Given the
high concentration of ATP used to stimulate ceramide accu-
mulation, we next determined whether the ATP-induced cera-
mide production is mediated by P2X7 or by another P2
receptor. In RAW 264.7 macrophages, 2 h pretreatment with
oATP, which prevents P2X7 activation, completely inhibited
ceramide accumulation induced by 2 h stimulation with ATP
(Fig. 2A). 500 lM BzATP, a potent P2X7 agonist, triggeredceramide accumulation as eﬃciently as ATP (Fig. 2B). In con-
trast, 3 mM UTP, a P2Y agonist, had no eﬀect (Fig. 2B). Alto-
gether, these data implicate P2X7 as the P2 receptor
responsible for ceramide production in macrophages.
3.3. ATP induces ceramide accumulation through activation of
the de novo biosynthesis pathway
To examine the pathways involved in ATP-induced cera-
mide accumulation, we analyzed the eﬀect of ATP on the turn-
over of [3H]choline-labeled sphingomyelin. ATP did not
reduce signiﬁcantly sphingomyelin levels over a time-course
of 2 h (data not shown), suggesting that sphingomyelinases
are not involved. We next examined the eﬀect of CS, bChlor
and ISP-1, three potent inhibitors of serine palmitoyltransfer-
ase [25–27]. CS, bChlor and ISP-1 inhibited the accumulation
of ceramide following ATP treatment by 64%, 70% and 53%,
respectively (Fig. 3A). We next used PDMP, a potent inhibitor
of glucosylceramide synthase [28], to examine whether the in-
creased ceramide might be due to a lower rate of its conversion
to glucosylceramide and other complex glycosphingolipids.
PDMP slightly increased ceramide in untreated cells but mark-
Fig. 2. ATP-induced ceramide accumulation is mediated by P2X7 receptors. RAW 264.7 macrophages were pre-incubated for 2 h with 250 lM
oATP and then treated with 3 mM ATP for an additional 2 h (A) or treated with 3 mM ATP, 500 lM BzATP or 3 mM UTP for 2 h (B). Ceramide
levels were then determined as described in Section 2. Data are means ± S.E.M of three independent experiments.
Fig. 3. P2X7 induces cell-death through de novo synthesis of ceramide. (A) RAW 264.7 macrophages were pre-incubated with 300 lM CS or 5 mM
bChlor or 5 lM ISP-1 and then treated for 2 h with 3 mM ATP. (B) RAW 264.7 macrophages were pre-incubated with 10 lM PDMP and then
treated for 30 min with 3 mM ATP. Ceramide levels were then determined as described in Section 2. Data are means ± S.E.M. of 3–4 independent
experiments. (C) RAW 264.7 macrophages were pre-incubated with 5 mM bChlor or 10 lM PDMP and then treated for 2 h with 3 mM ATP. LDH
released were then determined as described in Section 2. Data are means ± S.E.M. of three independent experiments. *Signiﬁcantly diﬀerent from
ATP alone.
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(Fig. 3B). Thus, it is unlikely that decreased conversion of cer-
amide to glucosylceramide is responsible for its accumulation.
Taken together, these results suggest that ceramide accumula-
tion induced by ATP occurs mainly by stimulation of the de
novo synthesis pathway.
3.4. ATP-induced macrophage death involves de novo ceramide
biosynthesis
Previous studies have shown that stimulation of P2X7 with
high concentrations of ATP induces macrophage death by
necrosis and apoptosis [11,12]. In addition, prolonged stimula-
tion of P2X7 induced the death of RAW 264.7 macrophages
measured by the MTT assay [24]. We also found that pro-
longed P2X7 stimulation leads to a time-dependent release of
LDH from RAW 264.7 cells. 1 LDH release in the extracellu-
lar medium occurs only between 60 and 90 min, a latter time1 Marie-Noe¨lle Raymond and Herve´ Le Stunﬀ, unpublished data.where ceramide accumulation starts already to plateaued.
Since ceramide production preceded LDH release, these data
indicate that ceramide production do not arise from the loss
of cell membrane integrity. To determine whether ceramide
could be involved in ATP-induced macrophage death, RAW
264.7 cells were pretreated with an inhibitor of de novo cera-
mide synthesis. It was found that bChlor provided signiﬁcant
protection from the cytotoxic eﬀect of ATP, by reducing the
LDH release by 49% (Fig. 3C). As expected, PDMP, which
potentiates the ceramide accumulation in RAW 264.7 macro-
phages induced by ATP, raised the amount of LDH released
by 1.5-fold compared to ATP alone (Fig. 3C). Altogether,
these results suggest that de novo synthesis of ceramide may
contribute to ATP-mediated macrophage lysis.
3.5. P2X7-induced caspase-3/7 activation depends on de novo
ceramide biosynthesis
Caspases are cysteine proteases, which play a central role in
the regulation of cell-death [29]. Activation of various caspases
has been implicated in P2X7-mediated apoptosis [7,8,11,30]. In
Fig. 4. P2X7-induced ceramide accumulation is caspase-independent. (A) RAW 264.7 macrophages were incubated with 3 mM ATP for the
indicated times. Caspase-3/7 activity was then determined as described in Section 2. (B) RAW 264.7 macrophages were pre-treated with 50 lM
ZVAD for 30 min and then incubated for 3 h with 3 mM ATP. LDH release was then determined as described in Section 2. (C) RAW 264.7
macrophages were pre-treated with 50 lM ZVAD for 30 min and then incubated for 2 h with 3 mM ATP. Ceramide levels were then determined as
described in Section 2. Data are means ± S.E.M. of three independent experiments. (D) RAW264.7 macrophages were pre-treated with 5 mM bChlor
for 30 min and then incubated for 3 h with 3 mM ATP. Caspase-3/7 activity was then determined as described in Section 2. *Signiﬁcantly diﬀerent
from ATP alone.
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troversial, since both caspase-dependent and independent
mechanisms have been described [7,12]. Therefore, we ﬁrst ver-
iﬁed that P2X7 stimulation increased caspase-3/7 activity in
RAW 264.7 macrophages. Stimulation of RAW 264.7 cells
with ATP resulted in increased caspase-3/7 activity only after
1 h of treatment and reached an 8-fold increase after 3 h of
stimulation (Fig. 4A). We next analyzed the role of caspases
in ATP-induced macrophage lysis. We found that ZVAD, a
broad spectrum caspase inhibitor, abolished LDH release from
RAW 264.7 macrophages induced by ATP (Fig. 4B). Having
determined that ATP triggers a caspase-dependent lysis and
knowing that ceramide can act both as a target and an induc-
tor of caspase activity [16,31], we next assessed whether ATP-
induced ceramide accumulation was caspase-dependent.
ZVAD, at the concentration suﬃcient to abolish LDH release,
had no eﬀect on ATP-induced ceramide accumulation in RAW
264.7 macrophages (Fig. 4C). In contrast, bChlor, the de novo
ceramide synthesis inhibitor, reduced by almost 50% caspase-3/7 activation induced by ATP (Fig. 4D). Altogether these re-
sults indicate that P2X7 regulates partially caspase-3/7 activa-
tion through the generation of ceramide.4. Conclusion
In conclusion, this study implicates ceramide generation as a
novel P2X7 eﬀector. More importantly, our data suggest that
the activation of de novo ceramide synthesis is involved in
ATP-induced macrophage death. In contrast to Fas-mediated
ceramide production in Jurkat T cells [32], P2X7-induced cer-
amide accumulation in macrophage is completely independent
of caspases. However, activation of caspases, which strongly
regulates ATP-mediated cell-death [7,8,11,30] required par-
tially de novo ceramide synthesis in macrophages. Altogether,
these results suggest that P2X7 stimulation induces macro-
phage death in a caspase-dependent manner, both through cer-
amide-dependent and independent mechanisms.
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non-selective membrane pores associated to cell-death [1]. The
cytoplasmic C-terminal tail of P2X7 is an important modula-
tor of these receptor functions [3–5,14,33]. Pore formation is
a rapid process in macrophages [34], which precedes ceramide
accumulation in RAW 264.7 cells, 1 suggesting that ceramide
does not regulate pore formation but rather will be dependent
on it. Interestingly, P2X7 harbors in its C-terminal part a puta-
tive TNF receptor-related death domain [35], in which muta-
tions lead to partial or total loss of function [3,4,10,36]. It is
known that TNF receptor stimulates ceramide production
through sphingomyelinases and de novo synthesis [37], involv-
ing protein–protein interactions with its death domain [38].
Thus, the P2X7 C-terminal region may have similar recep-
tor–protein complexes to induce ceramide production. Future
experiments will be needed to analyze in details the role of the
TNF receptor-related death domain in P2X7-induced cera-
mide production.
The identiﬁcation of ceramide as a P2X7 eﬀector opens new
strategies for analyzing the biochemical processes involved in
P2X7-mediated cell apoptosis/necrosis but also the killing of
intra-cellular bacteria by macrophages.
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